In this episode, John Cumbers chats with Michael Kamdar, President & CEO and Phil Paik, CTO, both of whom are at Molecular Assemblies—a San Diego-based life sciences company developing an enzymatic DNA synthesis technology designed to power the next generation of DNA-based products. The trio will discuss the competitive DNA synthesis landscape, Molecular Assemblies plans for commercialization, and what Mike and Phil envision for the future of the company and the industry.

Check out this week’s sponsor: Form Bio

Mike Kamdar is an industry veteran with business development and financing expertise who joined Molecular Assemblies in 2016. Mike has been in leadership positions within the biotech industry for numerous years, guiding companies such as Aguron, Pfizer and Hepion, Mike has a bachelor's in biology from St. Joseph’s University and an MBA from Villanova University.

Phil Paik has over 16 years of experience in technology innovation and platform development and joined Molecular Assemblies in 2020 after serving as an Associate Director of Engineering at Illumina—where he spent a number of years responsible for fluidics architecture and instrument development. Phil received both his master’s and PhD degrees from Duke University.

Connect with Mike & Phil: @molassemblies

Connect with John: @johncumbers

Stay updated on the latest news in synthetic biology, check out our weekly newsletter, and follow us on social media:

Twitter | LinkedIn | Facebook

Be sure you make it to our SynBioBeta events! Click here for more information.

The SynBioBeta Podcast